FDA NDC Directory · JSON-LD · Markdown

Lamivudine and Zidovudine

NDC 33342-003 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA090679
Dosage form / routeTABLET · ORAL
Active ingredientsLAMIVUDINE (150 mg/1)
ZIDOVUDINE (300 mg/1)
Marketing started20180830
Package count1

External sources

Source: openFDA. Public-domain (CC0).